The company has already been testing neural stem cells on human subjects in Switzerland. The recent approval will allow StemCells to conduct a trial in the U.S. and Canada aimed at showing how stem cells can improve or reverse effects of spinal cord paralysis.
Many scientists hope this approval will allow for more research gains to be made in the U.S. surrounding stem cells for regenerative medicine.
More Articles on Spine:
How Spine Surgeons Can Succeed With Consensus Building: Q&A With Dr. K. Daniel Riew
SpineCenterAtlanta Receives AAAASF Accreditation
Scoliosis Treatment: Do Race & Socioeconomic Status Make a Difference?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
